ENXTPA:IPNPharmaceuticals
Ipsen (ENXTPA:IPN) Valuation Check After New Rare Neuroscience Partnership With Origami Therapeutics
What Ipsen’s new rare neuroscience deal could mean for shareholders
Ipsen (ENXTPA:IPN) has agreed a global collaboration and option with Origami Therapeutics regarding a small molecule protein degrader program for a rare inherited neurodegenerative disorder, with the aim of broadening its neuroscience pipeline.
See our latest analysis for Ipsen.
That rare neuroscience deal lands at a time when Ipsen’s share price has climbed 18.5% over the last month and 12.3% over 90 days, while total...